As Director of Clinical Operations, Stefan Schöffel leads the team of Clinical Trial Managers at Heidelberg ImmunoTherapeutics and has oversight of all clinical activities. Stefan Schöffel joined the company in December 2020 as Clinical Project Manager and was appointed Director Clinical Operations in August 2021.

"After a 25-year career in clinical operations in leading clinical research organizations (CROs) worldwide, I felt the desire to reorient myself. I wanted to feel the spirit and can-do atmosphere of a promising biotech company and work close to the scientists who developed the compounds we are studying for the benefit of patients in our clinical trials," he explains.

Prior to joining Heidelberg ImmunoTherapeutics GmbH, Stefan Schöffel was Senior Director Regulatory and Start-Up at SyneosHealth, where he led a team of over 70 employees and was responsible for the start-up of dozens of sponsor projects in the DACH and MEA regions. Prior to that, he gained hands-on experience in clinical operations in various positions of increasing responsibility at Quintiles (now IQVIA), most recently as Director Clinical Operations and Director Study Start-Up. Stefan Schöffel holds a degree in Biology from the University of Erlangen-Nuremberg and is a certified Project Manager (IPMA Level D).